About CrescentDX
CrescentDX is a company based in Belfield (United States) founded in 2011. It operates as a B2B. CrescentDX has raised $2.16 million across 1 funding round from investors including Kernel Capital, Seroba Lifesciences and AIB Seed Capital Fund. CrescentDX operates in a competitive market with competitors including Imagen, CD Diagnostics, Emovi, MuscleSound and Osteosys, among others.
- Headquarter Belfield, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.16 M (USD)
in 1 rounds
-
Latest Funding Round
$2.16 M (USD), Series A
Jun 23, 2011
-
Investors
Kernel Capital
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CrescentDX
CrescentDX has successfully raised a total of $2.16M through 1 strategic funding round. The most recent funding activity was a Series A round of $2.16 million completed in June 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CrescentDX
CrescentDX has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Kernel Capital, Seroba Lifesciences and AIB Seed Capital Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm investing in the UK and the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Seroba Lifesciences is focused on life sciences venture capital investments.
|
Locked | Locked | Locked |
Investor details for CrescentDX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CrescentDX
Investment portfolio details for CrescentDX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CrescentDX
Detailed financials for CrescentDX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Crescentdx Comparisons
Peer comparison for CrescentDX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CrescentDX
CrescentDX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imagen, CD Diagnostics, Emovi, MuscleSound and Osteosys, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI solutions for detecting pathologies in medical images are developed.
|
|
| Locked | Locked | Locked |
Synovial fluid is tested for biomarkers in orthopedic disorders.
|
|
| Locked | Locked | Locked |
Developer of a knee assessment device
|
|
| Locked | Locked | Locked |
Muscular glycogen levels are measured non-invasively via ultrasound.
|
|
| Locked | Locked | Locked |
Bone mineral densitometer instruments are developed and marketed globally.
|
|
| Locked | Locked | Locked |
Diagnostic tests for osteoporosis are provided via urine-based biomarkers.
|
Detailed competitors of CrescentDX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Crescentdx
Complete news archive for CrescentDX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CrescentDX
CrescentDX was founded in 2011.
CrescentDX is headquartered in Belfield, United States. It is registered at Belfield, North Dakota, United States.
CrescentDX is a funded company, having raised a total of $2.16M across 1 funding round to date.
CrescentDX develops and markets diagnostic screening tests for osteoporosis, focusing on providing healthcare solutions, developing medical devices, diagnostic testing, and osteoporosis screening. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
CrescentDX's top competitors include CD Diagnostics, Imagen and Emovi.
CrescentDX has 3 investors. Key investors include Kernel Capital, Seroba Lifesciences, and AIB Seed Capital Fund.